Blue Owl Co-CEOs Remove Share Loans to Ease Stock Pressure
CEOs removed risky share-backed loans, easing fears, as investors worry about private credit and withdrawals.
Already have an account? Sign in.
CEOs removed risky share-backed loans, easing fears, as investors worry about private credit and withdrawals.
Supermicro announced a $7 billion equity and equity-linked offering to fund $39 billion in new AI server orders from over 20 customers.
Cellectis got FDA RMAT for lasme-cel, an off-the-shelf CAR-T therapy for hard-to-treat leukemia that may speed up patient access.
Cracker Barrel beat expectations, raised outlook, and saw shares jump as turnaround efforts and strong execution boost confidence.